
Sign up to save your podcasts
Or
Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.
5
22 ratings
Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.
1,185 Listeners
2,184 Listeners
1,765 Listeners
386 Listeners
125 Listeners
729 Listeners
89 Listeners
8,765 Listeners
142 Listeners
245 Listeners
14,993 Listeners
336 Listeners
14 Listeners
438 Listeners
372 Listeners